𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dose limits and the factors influencing risk estimates

Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
761 KB
Volume
22
Category
Article
ISSN
0146-6453

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hepatic trauma: Risk factors influencing
Hepatic trauma: Risk factors influencing outcome
✍ R. PrΔ›tre; G. Mentha; O. Huber; P. Meyer; J. Vogel; Professor A. Rohner πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 663 KB
Mitoxantrone and intermediate-dose cytos
Mitoxantrone and intermediate-dose cytosine arabinoside for poor-risk acute leukemias: Response to treatment and factors influencing outcome
✍ Dr Jorge Sierra; Albert GraΓ±ena; Francesc Bosch; Enric Carreras; Josep-Maria Mar πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 574 KB

Mitoxantrone (MIT, 12 mg/m', i.v. 5 days) and intermediate-dose cytosine arabinoside (IDAC 1 g/m2/12 h, i.v. 3 days) was given to 43 patients with poor-risk acute leukemias (AL). Moderate or severe toxicity was infrequent. The proportion of complete remissions (CR) in the main patient categories was

Estimating human cancer risk from the re
Estimating human cancer risk from the results of animal experiments: Relationship between mechanism and dose-rate and dose
✍ Dr. Harri Vainio; Elisabeth Cardis πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 664 KB

Experimental animals are often used as surrogate models in estimating human cancer risk from environmental agents when adequate epidemiological data are not available. Studies in experimental animals have usually evaluated the effects of exposure to single substances; however, humans receive combina